{"id":"https://openalex.org/W2004362201","doi":"https://doi.org/10.1517/13543780802636162","title":"Milatuzumab: a promising new agent for the treatment of lymphoid malignancies","display_name":"Milatuzumab: a promising new agent for the treatment of lymphoid malignancies","publication_year":2008,"publication_date":"2008-12-03","ids":{"openalex":"https://openalex.org/W2004362201","doi":"https://doi.org/10.1517/13543780802636162","mag":"2004362201","pmid":"https://pubmed.ncbi.nlm.nih.gov/19053886"},"language":"en","primary_location":{"id":"doi:10.1517/13543780802636162","doi":"https://doi.org/10.1517/13543780802636162","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780802636162","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056839401","display_name":"Tomer Martin Mark","orcid":"https://orcid.org/0000-0001-6996-0497","observed_orcids":["https://orcid.org/0000-0001-6996-0497"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tomer Mark","raw_affiliation_strings":["Weill Medical College of Cornell University, New York Presbyterian Hospital-Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, NY 10021, USA. tom9009@med.cornell.edu","+1 212 746 5536","TM and PM contributed equally to this work and share first authorship responsibilities","Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital-Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, NY 10021, USA. tom9009@med.cornell.edu","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]},{"raw_affiliation_string":"+1 212 746 5536","institution_ids":[]},{"raw_affiliation_string":"TM and PM contributed equally to this work and share first authorship responsibilities","institution_ids":[]},{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040141808","display_name":"Peter Martin","orcid":"https://orcid.org/0000-0001-7813-1551","observed_orcids":["https://orcid.org/0000-0001-7813-1551"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Martin","raw_affiliation_strings":["Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu; TM and PM contributed equally to this work and share first authorship responsibilities","+1 212 746 5536","TM and PM contributed equally to this work and share first authorship responsibilities","Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu; TM and PM contributed equally to this work and share first authorship responsibilities","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]},{"raw_affiliation_string":"+1 212 746 5536","institution_ids":[]},{"raw_affiliation_string":"TM and PM contributed equally to this work and share first authorship responsibilities","institution_ids":[]},{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037882455","display_name":"John Paul Leonard","orcid":"https://orcid.org/0000-0002-5083-1115","observed_orcids":["https://orcid.org/0000-0002-5083-1115"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P Leonard","raw_affiliation_strings":["Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu; TM and PM contributed equally to this work and share first authorship responsibilities","+1 212 746 5536","TM and PM contributed equally to this work and share first authorship responsibilities","Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu; TM and PM contributed equally to this work and share first authorship responsibilities","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]},{"raw_affiliation_string":"+1 212 746 5536","institution_ids":[]},{"raw_affiliation_string":"TM and PM contributed equally to this work and share first authorship responsibilities","institution_ids":[]},{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077846750","display_name":"Rub\u00e9n Niesvizky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben Niesvizky","raw_affiliation_strings":["Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu","+1 212 746 5536","Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964; +1 212 746 5536; tom9009@med.cornell.edu","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]},{"raw_affiliation_string":"+1 212 746 5536","institution_ids":[]},{"raw_affiliation_string":"Weill Medical College of Cornell University, New York Presbyterian Hospital\u2013Cornell Medical Center, Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, 525 East 68th Street, Payson Pavilion, 3rd Floor, NY 10021, USA +1 212 746 3964","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295","https://openalex.org/I4405272987"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1565,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.14488017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"18","issue":"1","first_page":"99","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7128999829292297,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7128999829292297,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.2703000009059906,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd74","display_name":"CD74","score":0.9919999837875366},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.8259999752044678},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7910000085830688},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.7570000290870667},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7630000114440918},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6770187616348267},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6317023634910583},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6139390468597412},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4373801350593567},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42436376214027405},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4090278446674347}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543780802636162","doi":"https://doi.org/10.1517/13543780802636162","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780802636162","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:19053886","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19053886","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W187561364","https://openalex.org/W1834370350","https://openalex.org/W1922227368","https://openalex.org/W1965734230","https://openalex.org/W1972700813","https://openalex.org/W1992443497","https://openalex.org/W1997353354","https://openalex.org/W1998434423","https://openalex.org/W2016224839","https://openalex.org/W2018035584","https://openalex.org/W2020793885","https://openalex.org/W2024520647","https://openalex.org/W2038982713","https://openalex.org/W2041129363","https://openalex.org/W2041197793","https://openalex.org/W2050704142","https://openalex.org/W2058015212","https://openalex.org/W2064426568","https://openalex.org/W2118895735","https://openalex.org/W2124790207","https://openalex.org/W2133836026","https://openalex.org/W2134364025","https://openalex.org/W2143369565","https://openalex.org/W2143882707","https://openalex.org/W2153665789","https://openalex.org/W2154643481","https://openalex.org/W2155366350","https://openalex.org/W2160305510","https://openalex.org/W2161048718","https://openalex.org/W2165831472","https://openalex.org/W2168267840","https://openalex.org/W2171379260","https://openalex.org/W2264088926","https://openalex.org/W2286165744","https://openalex.org/W2318772898","https://openalex.org/W2335236867","https://openalex.org/W2526330538","https://openalex.org/W2542576148","https://openalex.org/W2549384387","https://openalex.org/W2554306717","https://openalex.org/W2570622054","https://openalex.org/W2578158800","https://openalex.org/W2589000975","https://openalex.org/W2609515889"],"related_works":["https://openalex.org/W2589461025","https://openalex.org/W2241007778","https://openalex.org/W2559780739","https://openalex.org/W2017357058","https://openalex.org/W2029664590","https://openalex.org/W2526330538","https://openalex.org/W2247086321","https://openalex.org/W2552091371","https://openalex.org/W4252950657","https://openalex.org/W2112795579"],"abstract_inverted_index":{"BACKGROUND:":[0],"Non-Hodgkin's":[1],"lymphoma":[2,89,125],"and":[3,9,62,90,95,126],"multiple":[4,63,91,127],"myeloma":[5,92],"are":[6,82,118],"often":[7],"incurable":[8],"respond":[10],"to":[11,88,106],"a":[12,51,57,107,110],"limited":[13],"set":[14],"of":[15,21,26,68,116],"treatment":[16,58],"options.":[17],"The":[18,98],"selective":[19],"expression":[20],"CD74,":[22,55],"the":[23,27,46,69],"invariant":[24],"chain":[25],"MHC":[28],"class":[29],"II":[30],"molecule,":[31],"in":[32,121],"these":[33],"malignancies":[34],"provides":[35],"an":[36],"attractive":[37],"target":[38],"for":[39,49,59],"antibody-based":[40],"therapy.":[41],"OBJECTIVE:":[42],"This":[43],"review":[44,67],"evaluates":[45],"preclinical":[47],"data":[48],"milatuzumab,":[50],"humanized":[52],"antibody":[53],"targeting":[54],"as":[56],"non-Hodgkin's":[60],"lymphomas":[61],"myeloma.":[64,128],"METHODS:":[65],"A":[66],"literature":[70],"was":[71],"carried":[72],"out":[73],"using":[74,80],"PubMed.":[75],"Current":[76],"Phase":[77,113],"I":[78,114],"protocols":[79],"milatuzumab":[81,103,117],"summarized.":[83],"RESULTS/CONCLUSION:":[84],"Milatuzumab":[85],"is":[86,104],"cytotoxic":[87],"cell":[93],"lines":[94],"mouse-human":[96],"xenografts.":[97],"efficacy":[99],"dramatically":[100],"increases":[101],"when":[102],"attached":[105],"toxin":[108],"or":[109],"radioactive":[111],"agent.":[112],"trials":[115],"now":[119],"underway":[120],"human":[122],"subjects":[123],"with":[124]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}